Cagent Vascular’s Serranator PTA Device Studied for Pedal Interventions in Patients With CLTI

April 29, 2026—Cagent Vascular announced the publication of data demonstrating the safety and efficacy of the company’s Serranator percutaneous transluminal angioplasty (PTA) serration balloon catheter in pedal (inframalleolar) interventions for patients with chronic limb-threatening ischemia (CLTI).

Hjarta Care’s EVAR XplantR for Aortic Endograft Explantation Receives FDA De Novo Authorization

April 29, 2026—Hjarta Care announced that the FDA has granted de novo authorization for the EVAR XplantR, which is a purpose-built, single-use device designed for the safe and efficient explantation of aortic endografts used in endovascular aortic repair (EVAR).

Angiolutions Appoints International Endovascular Experts to Its Medical Board

April 29, 2026—Angiolutions announced the appointment of four internationally recognized vascular and endovascular specialists to its Medical Board, which will support the company as it advances development of the investigational A3-Shield system.

Vena MicroAngioscope System Used in First Commercial Cases in the United States

April 28, 2026—Vena Medical, a Kitchener, Canada—based developer of direct intravascular imaging systems, announced completion of the first commercial cases in the United States with the Vena MicroAngioscope system.

RODEO-PTAB Evaluates Single-Vessel Runoff in SFA Disease Treated With Endologix Detour System

April 28, 2026—Recent findings from a substudy of DETOUR2 demonstrated that percutaneous transmural arterial bypass (PTAB) may offer an alternative to leg bypass surgery for patients with complex peripheral arterial disease, even when distal vessel run off is severely limited.

Pain and QoL Data Presented for Gore’s Viabahn Fortegra Venous Stent

April 22, 2026—Gore & Associates announced new 12-month findings from the global GORE VIABAHN FORTEGRA Venous Stent IVC trial, which evaluated treatment of patients with symptomatic deep venous iliocaval obstruction.

Sonorous BosCath Neurovascular Catheter Cleared by FDA

April 22, 2026—Sonorous Neurovascular, a developer of solutions for cerebral venous diseases and neurovascular interventions, announced that it has received FDA 510(k) clearance for its BosCath, allowing the company to commercialize the next-generation neurovascular catheter in the United States.

Boston Scientific TheraSphere Y90 Glass Microspheres Evaluated in PROACTIF Registry

April 22, 2026—Boston Scientific announced an analysis of 989 patients with hepatocellular carcinoma (HCC) from the PROACTIF prospective real-world registry.